Preliminary findings suggest that oral sodium bicarbonate administration could become a major addition to the armamentarium of renoprotective measures for individuals with chronic kidney disease.

are thought to have specific renoprotective effects in patients with diabetic and nondiabetic nephropathy. Some guidelines advocating the use of these drugs in renal disease, however, base their ...

Background: Previously the angiotensin II receptor blocker Irbesartan has been demonstrated to reduce the risk for progression from microalbuminuria to macroalbuminuria in type 2 diabetic patients ...

The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...